Silence Therapeutics Archives -

Gene silencing and mRNA: breakthroughs and barriers – the pharmaphorum podcast

On this week’s pharmaphorum podcast, editor in chief Jonah Comstock catches up with Dr. Marie Wikström Lindholm, SVP of molecular

Gene silencing and mRNA: breakthroughs and barriers – the pharmaphorum podcast

https://pharmaphorum.com/podcast/gene-silencing-mrna-breakthroughs-and-barriers/

On this week’s pharmaphorum podcast, editor in chief Jonah Comstock catches up with Dr. Marie Wikström Lindholm, SVP of molecular

Gene silencing and mRNA: breakthroughs and barriers – the pharmaphorum podcast

https://pharmaphorum.com/r-d/gene-silencing-and-mrna-breakthroughs-and-barriers/

Amgen is planning to push its olpasiran candidate for reducing lipoprotein(a) into phase 3 as quickly as possible

Amgen eyes swift move to ph3 for cardiovascular drug olpasiran

https://pharmaphorum.com/news/amgen-eyes-swift-move-to-ph3-for-cardiovascular-drug-olpasiran/

UK biotech Silence Therapeutics has launched an online game to raise the profile of the rare blood disorder

Silence Tx uses game to raise thalassaemia awareness

https://pharmaphorum.com/news/silence-tx-uses-game-to-raise-thalassaemia-awareness/

AstraZeneca has announced a collaboration with UK biotech Silence Therapeutics to develop gene silencing drugs for cardiovascular, renal,

AZ adds gene silencing tech to pipeline with Silence Therapeutics deal

https://pharmaphorum.com/news/az-adds-gene-silencing-tech-to-pipeline-with-silence-therapeutics-deal/

Silence claims late-stage drugs infringe patents.

Silence Therapeutics takes rival Alnylam to court in patent fight

https://pharmaphorum.com/news/silence-therapeutics-takes-rival-alnylam-court-patent-fight/

Silence Therapeutics